1. Home
  2. ACA vs SLNO Comparison

ACA vs SLNO Comparison

Compare ACA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACA
  • SLNO
  • Stock Information
  • Founded
  • ACA 2018
  • SLNO 1999
  • Country
  • ACA United States
  • SLNO United States
  • Employees
  • ACA N/A
  • SLNO N/A
  • Industry
  • ACA Metal Fabrications
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ACA Industrials
  • SLNO Health Care
  • Exchange
  • ACA Nasdaq
  • SLNO Nasdaq
  • Market Cap
  • ACA 4.2B
  • SLNO 3.8B
  • IPO Year
  • ACA N/A
  • SLNO 2014
  • Fundamental
  • Price
  • ACA $92.08
  • SLNO $65.76
  • Analyst Decision
  • ACA Strong Buy
  • SLNO Strong Buy
  • Analyst Count
  • ACA 3
  • SLNO 9
  • Target Price
  • ACA $112.00
  • SLNO $116.78
  • AVG Volume (30 Days)
  • ACA 194.9K
  • SLNO 1.7M
  • Earning Date
  • ACA 10-30-2025
  • SLNO 11-04-2025
  • Dividend Yield
  • ACA 0.21%
  • SLNO N/A
  • EPS Growth
  • ACA N/A
  • SLNO N/A
  • EPS
  • ACA 1.87
  • SLNO N/A
  • Revenue
  • ACA $2,675,500,000.00
  • SLNO $32,656,999.00
  • Revenue This Year
  • ACA $12.65
  • SLNO N/A
  • Revenue Next Year
  • ACA $6.22
  • SLNO $182.29
  • P/E Ratio
  • ACA $50.65
  • SLNO N/A
  • Revenue Growth
  • ACA 9.78
  • SLNO N/A
  • 52 Week Low
  • ACA $68.11
  • SLNO $41.50
  • 52 Week High
  • ACA $113.43
  • SLNO $90.32
  • Technical
  • Relative Strength Index (RSI)
  • ACA 46.78
  • SLNO 50.66
  • Support Level
  • ACA $90.90
  • SLNO $64.30
  • Resistance Level
  • ACA $95.11
  • SLNO $72.88
  • Average True Range (ATR)
  • ACA 2.41
  • SLNO 3.64
  • MACD
  • ACA 0.25
  • SLNO 0.68
  • Stochastic Oscillator
  • ACA 48.93
  • SLNO 52.63

About ACA Arcosa Inc.

Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: